Systemic inflammation markers independently associated with increased mortality in individuals with hyperuricemia: Results from the NHANES prospective cohort study

• Published in: Immunity, Inflammation and Disease Vol. 12; no. 10; pp. e70032 - n/a
• Main Authors: Ren, Tian, Zhou, Erye, Wu, Jian, Wang, Chao, Yin, Yufeng
• Format: Journal Article
• Language: English
• Published: England John Wiley & Sons, Inc 01.10.2024; John Wiley and Sons Inc; Wiley
• Subjects: Adult; Aged; Biomarkers - blood; Cardiovascular Diseases - blood; Cardiovascular Diseases - immunology; Cardiovascular Diseases - mortality; Cohort Studies; Female; Health insurance; Humans; Hyperuricemia - blood; Hyperuricemia - mortality; Inflammation - blood; Inflammation - immunology; Inflammation - mortality; Inflammation < Processes; Innate lymphocytes/Lti < Cells; Male; Middle Aged; Monocytes/Macrophages < Cells; Mortality; Neutrophils < Cells; Nutrition Surveys; Original; Prognosis; Prospective Studies; Risk Factors; Socioeconomic factors; Uric Acid - blood; Womens health; United States > US; Innate lymphocytes/Lti < Cells; Inflammation < Processes; Monocytes/Macrophages < Cells; Neutrophils < Cells

Background Hyperuricemia is associated with increased systemic inflammation. The systemic immune‐inflammation index (SII) and systemic inflammation response index (SIRI) are novel systemic inflammation markers and prognostic markers. However, no studies have evaluated the association between the SII...